Related StoriesNew research raise important queries about influence of statin therapy on performance of flu vaccinesNew vaccine applicant shows great guarantee at fighting respiratory syncytial virusHIV, Ebola seem to be of pet originBioNeutral recognizes the compelling have to provide a cost-effective answer to kill infections for global applications, specifically in developing countries especially hard strike by the H1N1 swine flu epidemic.Colorcon announces specific details on its patent positions for enteric coatings Colorcon, Inc., a owned subsidiary of BPSI Holdings Inc wholly., today announced specific details on its world-wide patent positions for enteric covering compositions in response to misleading statements manufactured in the international press, particularly in India. ‘Colorcon endeavors to supply best-in-class products and services to the pharmaceutical industry globally.’.